Vivodyne
PrivateLast Round
Series A
May 29, 2025
Total Funding Raised
$82M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Vivodyne operates in Healthcare & Life Sciences and is based in Philadelphia, Pennsylvania. Its latest recorded funding round was a Series A round in May 2025.
Vivodyne is a biotechnology company that develops a microfluidic bioengineering platform for advancing single-cell 4D phenomics and facilitating drug discovery and cellular therapies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Vivodyne Comparables
Compare Vivodyne with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Quris AI | 86% | |
| Emulate | 85% | |
| Hesperos Inc. | 85% |
For institutional investors. Book with your work email.
Vivodyne Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | May 29, 2025 | ||||
| Seed | Nov 22, 2023 | ||||
| Seed | Mar 30, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Vivodyne Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Lingotto | Series A |
| Khosla Ventures | Series A, Seed |
| Kairos Ventures | Series A, Seed |
| Helena Capital | Series A |
| Helena Special Investments | Series A |
| Fortius Ventures | Series A |
| CS Ventures | Series A, Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 24, 2026
Monthly visitors increased 48% MoM to 3.9K.
- Apr 1, 2026
Partnered with a majority of top 10 multinational pharmaceutical companies.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- launchesAug 25, 2026
Vivodyne introduces Series 2 TissueDisk, a biological chip that simultaneously grows hundreds of functional human tissues, in Pennsylvania.
- expands_facilitiesAug 20, 2026
In Aug ’26, Vivodyne opens what it calls the world’s largest human data center in California and has raised nearly $80 million across two rounds.
- receives_financingAug 19, 2026
Vivodyne received financing of $80M on Aug 1st '26.
- invests_into_assetsAug 19, 2026
Vivodyne establishes the largest human data center and raises nearly $80M to expand its operations in Aug '26.
- is_developingAug 18, 2026
Vivodyne is building an automated system in California that uses robotic labs, human tissue, and AI-designed experiments to replace animal testing and support studies on more than 3 million human tissues annually.
For institutional investors. Book with your work email.
Vivodyne Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Vivodyne's valuation, stock price, and market status.
Is Vivodyne a public or private company?
Vivodyne is a private company.
What is the current stock price of Vivodyne?
Vivodyne is a private company, so its shares have no public market price. Caplight tracks Vivodyne's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Vivodyne worth (valuation)?
Valuation information for Vivodyne is not publicly available.
Can I buy Vivodyne stock?
Vivodyne shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Vivodyne's last funding round?
Vivodyne's most recent funding round was Series A on May 29, 2025.
Who are the main investors in Vivodyne?
Key investors in Vivodyne include Khosla Ventures, Kairos Ventures.
Will Vivodyne IPO soon?
No public IPO plans have been announced for Vivodyne.
How can I track Vivodyne secondary market activity?
Caplight tracks bids, offers, and trades in Vivodyne's shares on secondary markets.